Reliance Chemotex Industries Ltd: Valuation Shifts Signal Renewed Price Attractiveness

Valuation Metrics Show Positive Movement

As of 12 Aug 2026, Reliance Chemotex Industries Ltd trades at ₹126.55, down 1.75% from the previous close of ₹128.80. The stock’s 52-week range spans from ₹107.40 to ₹191.95, indicating significant volatility over the past year. The company’s price-to-earnings (P/E) ratio currently stands at 17.40, a figure that has contributed to its valuation grade upgrade from very attractive to attractive. This P/E multiple is considerably lower than several peers in the Garments & Apparels sector, such as SBC Exports, which trades at a very expensive P/E of 57.88, and Pashupati Cotspinning, with a P/E of 85.22.

Price-to-book value (P/BV) is another key metric that has improved Reliance Chemotex’s valuation appeal. At 0.71, the P/BV ratio suggests the stock is trading below its book value, a classic indicator of undervaluation. This contrasts with many peers, where valuations are stretched; for instance, AYM Syntex’s P/BV is significantly higher, reflecting its expensive valuation status.

Enterprise Value Multiples and Profitability Ratios

Enterprise value to EBITDA (EV/EBITDA) ratio for Reliance Chemotex is 8.55, which is competitive within the sector. This multiple is lower than SBC Exports’ 65.55 and Ruby Mills’ 20.82, reinforcing the stock’s relative affordability. The EV to EBIT ratio is 13.38, while EV to capital employed and EV to sales stand at 0.90 and 0.95 respectively, indicating efficient capital utilisation compared to peers.

However, profitability metrics remain subdued. The company’s return on capital employed (ROCE) is 4.53%, and return on equity (ROE) is 4.06%, both modest figures that highlight challenges in generating strong returns despite attractive valuation multiples. Dividend yield is low at 0.41%, which may deter income-focused investors.

Peer Comparison Highlights Relative Value

Within the Garments & Apparels sector, Reliance Chemotex’s valuation stands out as attractive when juxtaposed with peers. Dollar Industries, rated very attractive, trades at a P/E of 14.54 and EV/EBITDA of 9.39, slightly more favourable but comparable. Indo Rama Synthetics also holds an attractive valuation with a P/E of 9.22 and EV/EBITDA of 8.13, but with a notably lower PEG ratio of 0.07, signalling stronger growth expectations.

Conversely, several companies in the sector are classified as expensive or very expensive, including Faze Three (P/E 44.19), Ruby Mills (P/E 28.77), and One Global Services (P/E 17.59 but with higher EV/EBITDA). This contrast underscores Reliance Chemotex’s improved price attractiveness, although the company’s micro-cap status and lower profitability metrics temper enthusiasm.

Stock Performance Relative to Sensex and Historical Returns

Reliance Chemotex’s recent stock returns have been mixed and generally underwhelming compared to the broader market. Over the past week, the stock was flat at 0.00%, while the Sensex declined by 0.35%. Over one month, the stock fell by 3.25%, contrasting with a 0.75% gain in the Sensex. Year-to-date, Reliance Chemotex has declined 5.17%, whereas the Sensex has dropped 8.29%, indicating a slightly better relative performance in 2026 so far.

Longer-term returns paint a more challenging picture. Over one year, the stock has declined 23.81%, significantly underperforming the Sensex’s 3.04% loss. Over three years, Reliance Chemotex has fallen 30.85%, while the Sensex has gained 19.64%. Even over five years, the stock is down 10.06%, compared to the Sensex’s robust 43.33% gain. However, over a decade, Reliance Chemotex has delivered a strong cumulative return of 123.23%, though still trailing the Sensex’s 180.53% rise.

Mojo Score and Grade Update Reflect Caution

Despite the improved valuation parameters, MarketsMOJO assigns Reliance Chemotex a Mojo Score of 28.0, categorising it as a Strong Sell. This represents a downgrade from the previous Sell rating on 4 May 2026. The micro-cap company’s low score reflects concerns over profitability, growth prospects, and relative underperformance despite attractive valuation multiples. Investors should weigh these factors carefully when considering exposure to this stock.

Investment Implications and Outlook

The recent upgrade in valuation grade from very attractive to attractive for Reliance Chemotex Industries Ltd signals a more favourable entry point for value-oriented investors. The stock’s P/E of 17.40 and P/BV of 0.71 suggest it is trading at a discount relative to book value and many peers, offering potential upside if operational performance improves.

However, the company’s modest ROCE and ROE, combined with a low dividend yield, highlight ongoing challenges in generating shareholder returns. The downgrade to a Strong Sell Mojo Grade further emphasises caution, reflecting concerns about growth sustainability and competitive pressures within the Garments & Apparels sector.

Investors should consider the stock’s mixed performance relative to the Sensex, particularly its significant underperformance over the past one and three years. While the valuation metrics are appealing, the fundamental outlook remains uncertain, and the micro-cap status adds liquidity and volatility risks.

In summary, Reliance Chemotex Industries Ltd presents an intriguing valuation case but requires careful analysis of operational improvements and sector dynamics before committing capital. Monitoring quarterly earnings, margin trends, and peer developments will be critical to reassessing the stock’s attractiveness going forward.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today